- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03034252
Retrospective Evaluation of Liposarcoma (RELiSa)
January 25, 2017 updated by: Harrasser, Technical University of Munich
Retrospective Evaluation of Survival after Liposarcoma
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bavaria
-
Munich, Bavaria, Germany, 81675
- Klinikum rechts der Isar
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with Liposarcoma treated at our clinic
Description
Inclusion Criteria:
- Patients with Liposarcoma treated surgically at our clinic
Exclusion Criteria:
- N/A
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Survival rate
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2016
Primary Completion (Actual)
January 1, 2017
Study Completion (Actual)
January 1, 2017
Study Registration Dates
First Submitted
January 22, 2017
First Submitted That Met QC Criteria
January 25, 2017
First Posted (Estimate)
January 27, 2017
Study Record Updates
Last Update Posted (Estimate)
January 27, 2017
Last Update Submitted That Met QC Criteria
January 25, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 448/11
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Survival , Tumor
-
Beijing Friendship HospitalUnknownDeath | Complication | Survival | Periampullary TumorChina
-
Beijing Chao Yang HospitalRecruitingLocal Recurrence of Malignant Tumor of Rectum | Circumferential Resection Margin | Intraoperative Perforation of Rectum | Disease-free Survival | Overal SurvivalChina
-
Università degli Studi dell'InsubriaCompletedResidual Tumor | Overall Survival | Disease-free SurvivalItaly
-
Assistance Publique - Hôpitaux de ParisCompletedProstatic Neoplasms | Neoplasms, Hormone-Dependent | Survival Rate | Disease-Free Survival | Tumor Markers, BiologicalFrance
-
Peking University First HospitalCompletedOverall SurvivalChina
-
Columbia UniversityBill and Melinda Gates Foundation; United NationsCompletedChild SurvivalEthiopia, Ghana, Kenya, Malawi, Mali, Nigeria, Rwanda, Senegal, Tanzania, Uganda
-
University of SienaCompletedRestoration Survival
-
Matteo's FriendsRecruitingRecurrence Free SurvivalItaly
-
Metabolic Technologies Inc.Koach Sport and NutritionCompletedSurvival TrainingIsrael
-
ChimerixTerminated
Clinical Trials on Patients with Liposarcoma
-
University of Sao Paulo General HospitalCompletedSurgical Procedure, Unspecified | Liposarcoma of Soft TissueBrazil
-
National Taiwan University HospitalNot yet recruitingEducation, MedicalTaiwan
-
Hamid Al-Essa Organ Transplant CenterCompletedCOVID-19 Positive Patients With Acute Kidney InjuryKuwait
-
Prince of Songkla UniversityCompletedGastroesophageal Reflux DiseaseThailand
-
Yonsei UniversityCompletedMedical StudentsKorea, Republic of
-
University Hospital, BordeauxCompletedFrom the Model to the Adaptation of a Therapeutic Education Program (TEP) in Cancer Research (MODAP)Health Services ResearchFrance
-
Ankara Etlik City HospitalNot yet recruitingPain, Postoperative | Nausea, Postoperative | Vomiting, Postoperative
-
Centre Hospitalier de CornouailleCompletedCovid19 | Hematologic Malignancy | Vaccine Response ImpairedFrance
-
University Hospital, Strasbourg, FranceTerminated
-
Real Fundación Victoria EugeniaUniversidad de Murcia; Medtep Inc.Unknown